Category Archives: Uncategorized

Extend Biosciences has been awarded a third patent

Extend Biosciences’ third patent has been awarded by the USPTO. The patent, titled “Insulin Vitamin D Conjugates” issued April 11, 2017 (US 9,616,109). 

Founder Laura Hales wins the WIB Lobster Pot pitch competition

In a Shark Tank-style event sponsored by Women In Bio, Extend Biosciences founder Laura Hales, Ph.D. won first prize (an All-Clad Lobster Pot!) in the pitch competition in front of >100 audience members and 4 investors.  The event, held at LabCentral, featured 6 companies pitching from life sciences and healthcare, and was moderated by Marian Nakada of JJDC.

See event details here ->

Extend Biosciences is awarded a Phase I grant from NIAID

Extend Biosciences was awarded a Phase I SBIR grant from the National Institute of Allergy and Infectious Disease to work on a program for acute radiation syndrome.

Extend Biosciences says goodbye to LabCentral

Extend Biosciences has completed their 3-year maximum stay at LabCentral and said goodbye to fellow residents and staff at a happy hour in the playroom with Advirna. On February 1, Extend Bio will move to a shared laboratory facility in Newton.

See the post on Twitter->

Extend Biosciences’ Founder Laura Hales Speaks on a Panel on Women in STEM at a Regional SBIR Conference

Laura Hales, Cofounder of Extend Biosciences, spoke about her journey in biotech and entrepreneurship and path to successfully obtaining SBIR funding on a panel on October 5. The panel was moderated by Esther Morales, Executive Director of the National Women’s Business Council, and included Barbara Fox, PhD, Marian Nakada, PhD, and Joanne Kamens, PhD. The title of the panel was “It’s All of Our Business: Succeeding as a Woman in STEM” and was part of the preconference to the 2016 SBIR New England Regional Summit at MIT.

Extend Biosciences Featured in the NSF Innovation Zone at BIO2016

Extend Biosciences was featured in the NSF Innovation Zone at the BIO International Convention 2016 in San Francisco, CA.  The company received complimentary passes to the Convention, and the technology was showcased at the company’s kiosk in the Innovation Zone with a poster and a pitch presentation by CEO Tarik Soliman.

Read the press release here->

Extend Biosciences has been Awarded a Second Patent with Broad Claims

Extend Biosciences’ second patent has been awarded by the USPTO. The patent, titled “Carriers for Improved Drug Delivery” issued March 22, 2016 (US 9,289,507). The patent includes broad claims for the use of vitamin D to improve the pharmacokinetic properties of therapeutic entities.

CEO Tarik Soliman Speaks at the Peptide Showcase East Conference

Extend Biosciences’ CEO Tarik Soliman gave a talk at the Boulder Peptide Symposium’s Peptide Showcase East conference held at the Microsoft NERD Center in Cambridge, MA. The talk was titled “Harnessing the biology of Vitamin D to enable sustained delivery of peptides and proteins.”

Watch video here ->

Extend Biosciences’ First Patent has been Awarded by the USPTO

Extend Biosciences’ first patent has been awarded. The patent, titled “Vitamin D-ghrelin Conjugates” issued Nov. 3, 2015 (US 9,173,940).

Extend Biosciences Featured in the Innovation Zone at the BIO2015 International Convention

Extend Biosciences was one of 12 NSF awardee companies with treatment-related technologies that was featured in the Innovation Zone at the BIO International Convention 2015 in Philadelphia, PA.  The company received complimentary passes to the Convention, and the technology was showcased at the company’s kiosk in the Innovation Zone with a poster and a pitch presentation by CEO Tarik Soliman.

See the press release here ->